Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737.
2018-03-28

2018. Noll T, Schultze-Seemann S, Kuckuck I, Michalska M, Wolf P. Cancer Immunology, Immunotherapy 67(3): 413-422.